A

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

Director – Clinical Development

Biology & BiotechConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • An MD or equivalent is required; an equivalent combination of relevant education and experience may be considered.
  • Targeted background includes three years of relevant medical or clinical practice, related research, or academic experience within the pharmaceutical industry.
  • Experience with medical monitoring, clinical research, and creating and implementing development plans and clinical studies is desired; an equivalent combination of relevant education and experience may be considered.
  • Experience across several phases of pharmaceutical development is desired.
  • Established relationships with thought leaders and investigators in depression and other mood disorders are required.
  • Experience in rare disease and/or neurology is strongly preferred.
  • Demonstrated ability to work within a geographically diverse, cross-functional team environment is required.
  • Experience interacting with senior leaders, including global regulatory agencies, is required.
  • Strong verbal and written communication, interpersonal, management, and organizational skills are required.
  • Problem-solving and conflict-resolution abilities are required.
  • Ability to engage in open, constructive, and continuous dialogue with company stakeholders is required.
  • Willingness and ability to travel domestically and internationally are required.
  • Ability to perform regular standing, walking, sitting, and hand use; occasionally reaching, climbing, balancing, stooping, kneeling, crouching, and lifting or moving up to 20 pounds is required.
  • Ability to travel independently overnight and/or work after hours as required by travel schedules or business needs is required.

Responsibilities

  • Create and execute global clinical development plans consistent with the company’s vision and mission.
  • Ensure optimal planning, implementation, and interpretation of clinical studies, including synopsis and protocol development, medical monitoring, data analysis, and final-report writing.
  • Build and maintain productive relationships with investigators, thought leaders, centers of excellence across the scientific community, and colleagues across the organization.
  • Interact frequently with study sites to support study awareness, patient recruitment, and quality of study conduct.
  • Communicate appropriate program issues and results to key internal and external stakeholders.
  • Support regulatory interactions, including submission of regulatory documents and presentations.
  • Provide clinical and scientific expertise to advance compounds from discovery through full development and subsequent life-cycle management.
  • Review business-development opportunities and translate business needs into cost-effective development strategies that provide competitive advantage and meet regulatory requirements.
  • Comply with current local and international regulations, laws, scientific and regulatory guidance, Good Clinical Practices, and company policies and procedures.
  • Perform other duties as assigned.

Desired Qualifications

  • Board certification or eligibility is strongly preferred.
  • Experience in rare disease and/or neurology is strongly preferred.
  • Experience with medical monitoring, clinical research, and creating and implementing development plans and clinical studies is desired.
  • Applicable industry experience across several phases of development is strongly desired.

About the Company

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

ACADIA Pharmaceuticals develops and commercializes medicines for central nervous system (CNS) disorders, focusing on neurological and psychiatric conditions with unmet medical needs. Its work centers on identifying drug candidates, advancing them through preclinical and clinical trials, and, upon regulatory approval, bringing therapies to market. Its products address CNS conditions such as Parkinson's disease psychosis, reflecting a commitment to treating complex brain disorders. The company combines in-house research with potential strategic collaborations to expand its portfolio and reach. Unlike peers that rely on a single development path, ACADIA emphasizes a broad pipeline and the ability to commercialize approved therapies, aiming to provide effective CNS treatments to patients and improve outcomes in mental health and neuroscience.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1993

Recently Posted Jobs

Explore more opportunities at Acadia Pharmaceuticals

See more jobs